ResearcherUniversity of MichiganActive in the last 2 years

Max S. Wicha

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-4180-7727; OpenAlex author ID A5059956218; NIH RePORTER profile ID 1872561. Sources: OpenAlex.

Their work

Papers: 3
Trials: 0
Grants: 1
Labs led: 0
Collaborators: 12

Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: none · 2021: 1 paper · 2022: none · 2023: 1 paper · 2024: none · 2025: 1 grant

Papers 3

Grants 1

Administrative Supplement P30 Cancer Center Support Grant (CCSG): Phase 1 Study of Olaparib in Combination with Durvalumab (MEDI4736) and Concurrent Radiation … P30CA046592 ↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Eric R. Fearon · 1 shared grant, 2025 · strength 1.07
- Grant Administrative Supplement P30 Cancer Center Support Grant (CCSG): Phase 1 Study of Olaparib in Combination with Durvalu… P30CA046592 ↗
Grace G. Bushnell · 2 shared papers, 2021–2023 · strength 0.41
- Paper Tumor microenvironment interactions with cancer stem cells in pancreatic ductal adenocarcinoma. DOI 10.1016/bs.acr.2023.02.007 ↗
- Paper Disease-induced immunomodulation at biomaterial scaffolds detects early pancreatic cancer in a spontaneous model. DOI 10.1016/j.biomaterials.2020.120632 ↗
António M. Palma · 1 shared paper, 2023 · strength 0.26
- Paper Tumor microenvironment interactions with cancer stem cells in pancreatic ductal adenocarcinoma. DOI 10.1016/bs.acr.2023.02.007 ↗
Rajan Gogna · 1 shared paper, 2023 · strength 0.26
- Paper Tumor microenvironment interactions with cancer stem cells in pancreatic ductal adenocarcinoma. DOI 10.1016/bs.acr.2023.02.007 ↗
Howard C. Crawford · 1 shared paper, 2021 · strength 0.15
- Paper Disease-induced immunomodulation at biomaterial scaffolds detects early pancreatic cancer in a spontaneous model. DOI 10.1016/j.biomaterials.2020.120632 ↗
Lonnie D. Shea · 1 shared paper, 2021 · strength 0.15
- Paper Disease-induced immunomodulation at biomaterial scaffolds detects early pancreatic cancer in a spontaneous model. DOI 10.1016/j.biomaterials.2020.120632 ↗
Mina Zeinali · 1 shared paper, 2018 · strength 0.07
- Paper Profiling Heterogeneous Circulating Tumor Cells (CTC) Populations in Pancreatic Cancer Using a Serial Microfluidic CTC … DOI 10.1002/adbi.201800228 ↗
Diane M. Simeone · 1 shared paper, 2018 · strength 0.07
- Paper Profiling Heterogeneous Circulating Tumor Cells (CTC) Populations in Pancreatic Cancer Using a Serial Microfluidic CTC … DOI 10.1002/adbi.201800228 ↗
Sunitha Nagrath · 1 shared paper, 2018 · strength 0.07
- Paper Profiling Heterogeneous Circulating Tumor Cells (CTC) Populations in Pancreatic Cancer Using a Serial Microfluidic CTC … DOI 10.1002/adbi.201800228 ↗
Jiaqi Shi · 1 shared paper, 2018 · strength 0.07
- Paper Profiling Heterogeneous Circulating Tumor Cells (CTC) Populations in Pancreatic Cancer Using a Serial Microfluidic CTC … DOI 10.1002/adbi.201800228 ↗
Vaibhav Sahai · 1 shared paper, 2018 · strength 0.07
- Paper Profiling Heterogeneous Circulating Tumor Cells (CTC) Populations in Pancreatic Cancer Using a Serial Microfluidic CTC … DOI 10.1002/adbi.201800228 ↗
Kyle Clifford Cuneo · 1 shared paper, 2018 · strength 0.07
- Paper Profiling Heterogeneous Circulating Tumor Cells (CTC) Populations in Pancreatic Cancer Using a Serial Microfluidic CTC … DOI 10.1002/adbi.201800228 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.